ClinicalTrials.Veeva

Menu

End-Tidal Carbon Dioxide Monitoring Device for Sedation During Endoscopic Ultrasonography

N

Naval Military Medical University

Status

Unknown

Conditions

Endoscopic Ultrasonography
Sedation
Monitoring

Treatments

Device: Novel end-tidal CO2 monitoring device
Device: SpO2 and respiratory motion monitoring

Study type

Interventional

Funder types

Other

Identifiers

NCT04549623
ETCO2-MDS

Details and patient eligibility

About

To meet the needs of both operators and patients, moderate and deep sedation has been widely used in digestive endoscopy, which is invasive and painful. With its pleasant effects, sedation has complications nevertheless. And respiratory depression is the most common one, which makes respiratory monitoring significant. SpO2 and respiratory motion are regularly monitored without satisfying timeliness or sensitivity. Capnography with current device is only able to detect either oral or nasal breathing. The present study was designed to test the effect of the investigator's modified End-Tidal Carbon Dioxide (ETCO2) monitoring device for sedation during endoscopic ultrasonography-guided fine needle aspiration.

Enrollment

480 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Scheduled for ultrasonography-guided fine needle aspiration
  • Adult patients aged 18 to 65 years
  • American Society of Anesthesiologists (ASA) Physical Status Classification I-III
  • Subjects provide informed consent

Exclusion criteria

  • Full stomach or upper gastrointestinal tract obstruction
  • Baseline pulse oximetric saturation (SpO2) <95% while breathing room air
  • Obesity (BMI≥28kg/m2)or anticipated difficult airway
  • Cardiovascular or cerebrovascular events within 3 months
  • Pregnancy
  • Chronic opioid user
  • Allergic to anesthetics

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

480 participants in 2 patient groups

Group ETCO2
Experimental group
Description:
Novel end-tidal carbon dioxide monitoring device is used for sedation.
Treatment:
Device: Novel end-tidal CO2 monitoring device
Group Reg
Experimental group
Description:
Peripheral oxygen saturation (SpO2) and respiratory motion are regularly monitored during sedation.
Treatment:
Device: SpO2 and respiratory motion monitoring

Trial contacts and locations

1

Loading...

Central trial contact

Jia-feng Wang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems